Literature DB >> 10511213

Tarsal switch procedure for the surgical rehabilitation of the eyelid and socket deficiencies of the anophthalmic socket.

G G Massry1, A Hornblass, P Rubin, J B Holds.   

Abstract

PURPOSE: To describe a tarsal transfer procedure, which we have named the "tarsal switch," to correct the eyelid malpositions and camouflage the socket defects of acquired anophthalmos.
METHODS: The technique consists of an upper eyelid tarsectomy, with transfer of the autologous tarsoconjunctival graft to the posterior lamella of the lower eyelid.
RESULTS: The operation was performed in 21 anophthalmic patients. In 16 patients with eyelid malpositions, excellent results (within 1 mm of the fellow eye) were attained in 100% of the patients with ptosis, and in 88% of patients with lower eyelid retraction. In the remaining 5 patients, orbital volume loss with secondary implant migration, inferior prosthetic displacement and eyelid asymmetry predominated. In these patients the anophthalmic orbital defects and eyelid asymmetry were masked well. Patient satisfaction was high and complications were few during an average follow-up interval of 16 months.
CONCLUSION: The tarsal switch procedure is useful in managing the eyelid malpositions and masking the orbital deficiencies of the anophthalmic socket.

Entities:  

Mesh:

Year:  1999        PMID: 10511213     DOI: 10.1097/00002341-199909000-00006

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  2 in total

1.  Clinical effects of conjunctiva-Müller muscle resection in anophthalmic ptosis.

Authors:  Sung Woo Ha; Jong Mi Lee; Woo Jin Jeung; Hee Bae Ahn
Journal:  Korean J Ophthalmol       Date:  2007-06

2.  Tarsal switch using an anterior approach to correct severe ptosis.

Authors:  Roberta Lilian Fernandes de Sousa Meneghim; Lucieni Barbarini Ferraz; Alicia Galindo-Ferreiro; Rajiv Khandekar; Hortensia Sanchez-Tocino; Silvana Schellini
Journal:  Arch Plast Surg       Date:  2018-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.